Prosecution Insights
Prosecution Insights
Tech Center 3700 • Art Units: 2863 3626 3681 3682 3685 3796
This examiner grants 12% of resolved cases
Kyle G. Robinson is assigned to Tech Center 3700 and Art Unit 2863. He has 213 resolved cases. The allowance rate for these cases is 11.7 percent. This 11.7 percent rate reflects the frequency of grants among the 213 resolved cases.
The interview lift is 16.6 percent. This 16.6 percent lift quantifies the increase in the probability of allowance when an interview is held versus when an interview is not held. The median days to allowance is 1421. This 1421 day figure is the median time for applications to reach a grant. Given the 11.7 percent allowance rate, the 16.6 percent interview lift is a strategic factor. The 1421 days to allowance provides a benchmark for the duration of the process. Practitioners should use the 16.6 percent lift to justify an interview, as it may help improve the 11.7 percent base allowance rate. The 213 resolved cases provide the context for these performance statistics.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18909810 | MEDICAL INFORMATION PROCESSING APPARATUS, MEDICAL INFORMATION PROCESSING SYSTEM AND MEDICAL INFORMATION PROCESSING METHOD | Non-Final OA | Canon Kabushiki Kaisha |
| 18882633 | METHOD, APPARATUS, DEVICE AND STORAGE MEDIUM FOR INFORMATION INTERACTION | Non-Final OA | Beijing Zitiao Network Technology Co., Ltd. |
| 17164462 | METHODS AND SYSTEMS FOR IDENTIFYING COMPATIBLE MEAL OPTIONS | Non-Final OA | KPN INNOVATIONS, LLC. |
| 19083834 | PRIME DIFFERENTIATION IN MEDICATION DELIVERY SYSTEM | Non-Final OA | Medtronic MiniMed, Inc. |
| 19052957 | CLINICAL TRIAL PLANNING DEVICE AND CLINICAL TRIAL PLANNING METHOD | Final Rejection | Hitachi, Ltd. |
| 18816106 | HEALTHCARE IMPROVEMENT BASED ON COMPOSITE HEALTHCARE SCORES | Non-Final OA | Hill-Rom Services, Inc. |
| 18763096 | METHOD AND SYSTEM FOR AUTOMATIC REMOTE PROGRAMMING OF INFUSION PUMPS | Non-Final OA | B. Braun Melsungen AG |
| 18847985 | OPTIMIZATION OF DOSING AND PRESCRIBING OF MEDICATION | Final Rejection | MannKind Corporation |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy